GSK’s combination brings together Fluticasone ... to Ultibro Breezhaler from their previous therapy (LABA+ICS * or LABA or LAMA) experienced superior improvements in lung function (trough ...

If there is an indication for an ICS, then LABA+LAMA+ICS has been shown superior to LABA+ICS and is therefore the preferred choice.” 1,8,9 In removing recommendations for LABA+ICS dual therapy ...